Latest Share Chat

ETX.L Share News (ETX)

ETX.L Information

There is currently no data for ETX

E-Therapeutics Appoints Sean Nicholson As Executive Director

Thu, 16th Oct 2014 07:40

LONDON (Alliance News) - E-Therapeutics PLC on Thursday said Sean Nicholson has been appointed as an executive director on its board.

Nicholson will join the board of the drug company in 2015 following his resignation as an equity partner in the corporate team at law firm Bond Dickinson LLP, the company said.

"Sean brings a wealth of knowledge and strong commercial skills. We intend to put his experience to good use as we continue to advance our drug development portfolio and apply our network pharmacology approach in drug discovery," said e-Therapeutics Chief Executive Officer Malcolm Young.

E-Therapeutics shares were untraded early Thursday, quoted at 28.25 pence.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

More News

4 Jun 2015 15:22

AGM, EGM Calendar - Week Ahead

21 May 2015 08:23

e-Therapeutics Says First Patient Enrolled In Phase Ib ETS2101 Trial

31 Mar 2015 08:21

e-Therapeutics Loss Widens As It Increases Development Spending

26 Feb 2015 14:12

e-Therapeutics Believes Drug Discovery Process Producing Higher Yield

23 Jan 2015 13:36

UK DIRECTOR DEALINGS SUMMARY: Shanta Gold Non-Executive Sells Stake

21 Jan 2015 11:42

DIRECTOR DEALINGS: e-Therapeutics Finance Director Buys 150,000 Shares

16 Sep 2014 09:08

e-Therapeutics Loss Widens On Pipeline Development; Chair To Retire

9 Jul 2014 07:37

UK MORNING BRIEFING: Deutsche Bank Raises Shell View, Cuts BP

4 Jul 2014 16:30

Daily Mail General Trust's Chairman sells £15.91m-worth of shares

Viscount Rothermere, the Chairman of Daily Mail and General Trust, has traded in £15.91m-worth of shares in the multi-media and information company. Selling the stock at 860p a piece, Rothermere benefited from the rise seen in the group's share price this week, which has seen it climbed 5.56%, or

4 Jul 2014 08:59

DIRECTOR DEALINGS: e-Therapeutics Finance Chief Buys 100,000 Shares

25 Jun 2014 16:02

DIRECTOR DEALINGS: e-Therapeutics Non-Executives Allotted New Shares

12 May 2014 11:49

e-Therapeutics Loss Widens As It Continues Pipeline Development

LONDON (Alliance News) - e-Therapeutics PLC Monday posted a widened pretax loss for 2013 as it continued to invest and develop its pipeline of products. The pharmaceutical company posted a pretax loss of GBP6.1 million, widened from GBP5.0 million, as it upped its research and development e

8 May 2014 13:30

UK MIDDAY BRIEFING: Centrica Warns, Barclays Restructures

LONDON (Alliance News) - British gas parent Centrica has issued a profit warning Thursday, blaming the extreme winter weather in the US but mild conditions in the UK, as well as the intense pressure that's been put on energy providers in the UK in recent months by politicians

8 May 2014 12:23

UK WINNERS & LOSERS: Standard Chartered, Barclays Lead FTSE 100 Risers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.
-------
FTSE 100 - WINNERS
-------
Barclays, up 4.9%. Barclays has detailed plans to shrink its investment bank with a new round

Latest Share Chat

ETX.L Share News (ETX)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

E-Therapeutics Appoints Sean Nicholson As Executive Director

Login to your account

Quickpicks are a member only feature

Login to your account